SUBSCRIBE
SUBSCRIBE

Maine

PRESS RELEASES
Press Releases
Pediatric Neurology Organizations Partner, Receive Funding to Build Registry for Neonatal Hypoxic Ischemic Encephalopathy
October 31, 2024
 · 
3 min read
News
ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2024
October 8, 2024
 · 
6 min read
Business
Ovation.io and PD Theranostics (PDTx) Complete Merger Creating a Multiomic Data Company Which Owns a Unique Population-Scale Biobank of Disease-Specific Biospecimens
September 5, 2024
 · 
7 min read
Press Releases
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024
August 14, 2024
 · 
12 min read
Business
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024
August 7, 2024
 · 
2 min read
Press Releases
Bot Image, Inc. Announces Verification of CPT payment code for its 3D Reconstruction of Prostate Tumors detected using bpMRI
July 31, 2024
 · 
2 min read
Business
ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 2024
July 10, 2024
 · 
6 min read
Chemomab Therapeutics Presents Data Supporting the Clinical Potential of CM-101 as a Novel Treatment for Primary Sclerosing Cholangitis at EASL 2024 and a Gordon Research Conference
June 6, 2024
 · 
7 min read
BioForest
ImmuCell Provides Update on Regulatory Status of Product Development Initiative for Re-Tain®
June 5, 2024
 · 
6 min read
Genetown
IDEXX Expands Test Menu for the Catalyst Platform to Support Veterinarians Globally in Diagnosing Pancreatitis
June 4, 2024
 · 
5 min read
Chemomab Therapeutics to Participate in Upcoming Scientific Conferences - May 17, 2024
May 17, 2024
 · 
3 min read
Business
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2024
May 14, 2024
 · 
11 min read
BioForest
ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024
April 9, 2024
 · 
6 min read
Business
ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023
February 27, 2024
 · 
11 min read
Genetown
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences - February 20, 2024
February 20, 2024
 · 
1 min read
Business
ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023Conference Call Scheduled for Wednesday, February 28, 2024 at 9:00 AM ET
February 16, 2024
 · 
2 min read
Business
IDEXX Announces Fourth Quarter and Full Year 2023 Results
February 5, 2024
 · 
35 min read
Business
IDEXX Laboratories to Release 2023 Fourth Quarter and Full Year Financial Results
January 23, 2024
 · 
1 min read
IDEXX Expands Fecal Dx® Antigen Testing Platform with Cystoisospora Detection, Marking the Second Platform Expansion in Less than Two Years
January 12, 2024
 · 
6 min read
IDEXX Announces Revolutionary Slide-Free Cellular Analyzer, IDEXX inVue Dx™ Transforming In-Clinic Workflows
January 12, 2024
 · 
6 min read
Load More